07-14 PharmaCorp to Seek Acquisition Opportunities CI
07-14 PHARMACORP ANNOUNCES CLOSING OF C$11.5 MILLION BOUGHT DEAL PUBLIC OFFERING AQ
07-07 PharmaCorp Rx to Raise C$10 Million in Private Placement of Units MT
07-07 PHARMACORP ANNOUNCES C$10 MILLION BOUGHT DEAL PUBLIC OFFERING AQ
07-06 PharmaCorp Rx Completes Acquisition of Eight Pharmacies in Eastern Canada MT
07-06 PharmaCorp Closes Previously Announced Eight-Store Acquisition and Provides Acquisition Pipeline Update AQ
07-06 PharmaCorp Rx Inc. completed the acquisition of Eight PharmaChoice Canada bannered pharmacies in Eastern Canada from two unnamed vendor groups for approximately CAD 24.2 million. CI
06-29 PharmaCorp Announces Definitive Agreement to Acquire Western Canada PharmaChoice Bannered Pharmacy NE
06-03 PharmaCorp Rx Initiated at Outperform, $0.70 Price Target at Raymond James MT
06-01 Earnings Flash (PCRX.V) PharmaCorp Reports Q1 Revenue $7.2M, Up 79.4% YoY MT
06-01 PharmaCorp Rx Inc. Announces First Quarter 2026 Financial Results AQ
06-01 PharmaCorp Rx Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
05-01 PharmaCorp Rx Inc. completed the acquisition of Prescription files, patient records, and related operational data located in Western Canada for CAD 0.3 million. CI
05-01 PharmaCorp to acquire eight pharmacies for $24.2 million RE
04-30 PharmaCorp Rx Inc. entered into definitive share purchase agreement to acquire Eight PharmaChoice Canada bannered pharmacies in Eastern Canada from two unnamed vendor groups for CAD 24.2 million. CI
04-30 PharmaCorp Rx Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 CI
12-12 PharmaCorp Rx to Acquire Pharmacy's Patient Files For $350,000 MT
12-11 PharmaCorp Rx Inc. signed a letter of intent to acquire Prescription files, patient records, and related operational data located in Western Canada for CAD 0.35 million. CI
12-01 PharmaCorp Q3 Net Loss Improves, Revenue Jumps MT
11-29 PharmaCorp Rx Inc. Announces Management Changes CI
11-29 PharmaCorp Rx Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 CI
11-13 PharmaCorp Rx Raises $23 Million in Public Offering of Units MT
11-07 PharmaCorp Rx Upsizes Bought-Deal Public Offering of Share Units to $20 Million MT
11-06 PharmaCorp Announces Upsized C$20 Million Bought Deal Public Offering GL
11-06 Canadian Investment Regulatory Organization Trade Resumption - PCRX AQ
No results match your criteria
  1. Stock Market
  2. Stocks
  3. PCRX Stock
  4. News PharmaCorp Rx Inc.